These encompass astrocytomas (IDH-mutant, WHO grade 2, 3, or 4) and oligodendrogliomas (IDH-mutant and 1p/19q-codeleted, WHO grade 2 or 3) [3]. The gene discussed is IDH2; the disease is oligodendroglioma.